Jacobus Wealth Management’s Pfizer PFE Stock Holding History

Jacobus Wealth Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	$253K	Hold	7,462	–	–	0.07%	149
2017 Q2	$238K	Hold	7,462	–	–	0.06%	149
2017 Q1	$242K	Sell	7,462 -3,083	-29%	-$97.2K	0.07%	141
2016 Q4	$325K	Hold	10,545	–	–	0.1%	131
2016 Q3	$339K	Buy	10,545 +3,083	+41%	+$103K	0.1%	135
2016 Q2	$249K	Sell	7,462 -5,402	-42%	-$172K	0.08%	150
2016 Q1	$362K	Hold	12,864	–	–	0.11%	152
2015 Q4	$394K	Hold	12,864	–	–	0.11%	144
2015 Q3	$383K	Hold	12,864	–	–	0.11%	138
2015 Q2	$409K	Hold	12,864	–	–	0.1%	147
2015 Q1	$425K	Hold	12,864	–	–	0.11%	137
2014 Q4	$380K	Sell	12,864 -1,181	-8%	-$33.9K	0.1%	144
2014 Q3	$394K	Sell	14,045 -2,561	-15%	-$71.9K	0.11%	148
2014 Q2	$468K	Sell	16,606 -163	-1%	-$4.65K	0.12%	142
2014 Q1	$511K	Buy	16,769 +5,702	+52%	+$170K	0.12%	131
2013 Q4	$322K	Buy	11,067 +1,054	+11%	+$30.7K	0.09%	166
2013 Q3	$273K	Hold	10,013	–	–	0.1%	149
2013 Q2	$266K	Buy	+10,013	New	+$277K	0.1%	146

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Jacobus Wealth Management's PFE Position: Q3 2017 in Review

Jacobus Wealth Management held its Pfizer (PFE) position steady in Q3 2017 at 7,462 shares worth $253K. The position accounts for 0.07% of the portfolio, ranked #149.

Jacobus Wealth Management first reported a position in PFE in Q2 2013 and has held it in 18 quarters since. The position peaked at $511K in Q1 2014. 2,042 funds tracked by Wall St. Rank hold PFE as of Q3 2017.

Jacobus Wealth Management held 7,462 shares of Pfizer worth $253K as of Q3 2017.
Jacobus Wealth Management left its Pfizer share count unchanged in Q3 2017.
Pfizer made up 0.07% of Jacobus Wealth Management's portfolio in Q3 2017, its #149 holding.
Jacobus Wealth Management first reported a position in Pfizer in Q2 2013 and has held it in 18 quarters since.
Jacobus Wealth Management's Pfizer position peaked at $511K in Q1 2014.
2,042 funds tracked by Wall St. Rank held Pfizer as of Q3 2017.

Based on Jacobus Wealth Management's 13F filing for Q3 2017, filed 31 Oct 2017.